Improved incidental memory with nicotine after semantic processing, but not after phonological processing.

What Was Tested

Researchers studied Therapeutic nicotine (patch, non-peptide) in this randomized controlled trial publication.

The present study investigated the effects of nicotine on memory using a depth of processing paradigm.

Why It Was Studied

However, the evidence is less clear for a nicotinic system being involved in mnemonic processing.

Who Took Part

By PubMed's age tags, the people studied were teenagers and adults, both men and women.

A double-blind design was used with participants (n = 40) smoking either a nicotine containing cigarette (n = 20) and a denicotinized cigarette (n = 20).

After smoking, each set of these participants was further subdivided into two groups (n = 10 for each).

How the Study Was Run

The researchers set it up as a randomized and double-blind study.

Random assignment meant chance, not the researchers, decided who got Therapeutic nicotine (patch, non-peptide) and who got the comparison, which limits bias.

Neither the participants nor the staff measuring them knew who was on Therapeutic nicotine (patch, non-peptide), so expectations could not easily colour the readings.

One group were presented with a series of trials each beginning with the presentation of a "decision word" which they had to say whether it represented something which was living or non-living (semantic-orienting).

The second group had to say whether the word had one syllable or two syllables (phonological or non-semantic orienting condition).

This decision was followed by a word in coloured ink whose colour participants were required to name as quickly as possible.

On completion of the whole task the participants were given an unexpected free recall test.

What Was Measured

The subject headings attached to it are Color Perception, Memory, Mental Processes, Nicotine, Nicotinic Agonists, Semantics and Speech Perception.

What This Means in Plain Language

The paper is a randomized and double-blind study of Therapeutic nicotine (patch, non-peptide).

The abstract goes on to report its results in about 4 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2001 (Psychopharmacology), a journal based in Germany.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.